Connect your AI

ICU Medical ICUI Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Merit Medical SystemsMMSI

$2.78M-78.9%

Baxter InternationalBAX

$8M-20.0%

MedtronicMDT

$97M-10.2%

HaemoneticsHAE

$1.15M+127%

NordsonNDSN

$24.21M+1,244%

Moog Inc.MOG.A

——

Other financials

Income statement

Revenue$530.2M-12.3%

Gross profit$206.2M-1.8%

Operating income$13.6M+5.4%

Net income$30.1M+295%

EPS (diluted)$1.20+290%

Balance sheet

Cash & equivalents$288.3M-0.5%

Total debt$1.4B-17.5%

Total equity$2.1B+6.3%

Total assets$4.0B-4.1%

Cash flow

Operating cash flow$38.9M-24.2%

CapEx$11.3M-22.7%

Free cash flow$27.6M-24.8%

Valuation

Market cap$3.39B-6.3%

Profitability

Gross margin37.9%+2.8pp

Operating margin2%-0.7pp

Net margin-0.3%-0.2pp

FCF margin4.2%-1.2pp

Returns & leverage

Return on equity-0.4%-0.2pp

Debt / equity0.6×-0.2×

Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ICU Medical's stock issuance proceeds?: ICU Medical (ICUI) reported stock issuance proceeds of $0 in Q1 2026.
How has ICU Medical's stock issuance proceeds changed year-over-year?: ICU Medical's stock issuance proceeds decreased by 100.0% year-over-year, from $133K to $0.
What is the long-term trend for ICU Medical's stock issuance proceeds?: Over 4 years (2021 to 2025), ICU Medical's stock issuance proceeds has grown at a -10.2% compound annual growth rate (CAGR), from $9.37M to $6.11M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.